The European Life Sciences Coalition (ELSC): Empowering the next generation of life-saving breakthroughs

0:00 Introducing the European Life Sciences Coalition. Launched in association with Invest Europe, the world's largest association of private capital providers.

0:12 The coalition brings together leading European life sciences investors, venture capital firms, research institutions, and legal firms.

0:22 Our mission is to strengthen Europe's strategic autonomy and ensure public health resilience by ensuring we don't just invent the future. We finance and scale it together.

0:29 Our members manage over 24 billion euros in life sciences-specific assets and have helped found or invest in more than 1,400 companies. We bring practical, market-driven perspectives to the core of European policy.

0:46 Through the ELSC, we are pushing for more effective mobilization of capital and a more integrated, efficient investment environment where innovative companies can thrive at home.

0:56 The challenges are already visible in the data.

1:00 Even the most promising companies are being pushed to seek financing elsewhere.

1:06 In the past 6 years, 66 out of 67 EU biotechnology companies that went public chose to list outside the EU.

1:15 Fragmented capital markets, the underutilization of private savings, and uneven regulatory processes are creating a progressive hollowing out of our ecosystem.

1:25 Europe has always been a powerhouse of science and talent.

1:29 But despite our strong scientific foundations, we are failing to scale our innovations at home. The gap is stark. European life sciences venture capital accounts for just 7% of the global market.

1:42 Without decisive action, we risk losing our long-term economic growth and patient access to the next generation of life-saving medicines.

1:52 The message from founders and investors is clear. It is time to build a healthy life sciences VC ecosystem.

1:59 Reach out to join the coalition today.